Clinical Trials
1
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Tumor-microenvironment Spatial Interaction to Identify Markers of Resistance to Therapy in HER2+ Breast Cancer Patients
Not yet recruiting
- Conditions
- HER2-positive Breast Cancer
- First Posted Date
- 2024-07-24
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- Giampaolo Bianchini
- Target Recruit Count
- 10
- Registration Number
- NCT06518382
- Locations
- 🇮🇹
IRCCS San Raffaele Hospital, Milano, Lombardy, Italy
News
No news found